Quote Date:

Data delayed 15 minutes Currency in USD

Company Description

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

  TTM2018201720162015
Revenue $81,382$61,187$76,450$71,890$70,074
Cost of Revenue Expense $27,373$20,130$25,354$21,685$21,536
Gross Profit $54,009$41,057$51,096$50,205$48,538
Selling, General & Administrative Expense $22,574$16,549$21,420$19,945$21,203
Operating Income $18,715$15,831$18,714$21,136$18,065
Interest Expense $1,029$755$934$726$552
Pretax Income $17,437$14,877$17,673$19,803$19,196
Provision Tax Income $15,895$2,622$16,373$3,428$3,787
Net Income $1,542$12,255$1,300$16,375$15,409
EBITDA $25,529$20,826$24,249$24,283$23,494
  TTM2018201720162015
Cash & Cash Equivalents $16,056$16,056$17,824$18,972$13,732
Short Term Receivables $14,048$14,048$13,490$11,699$10,734
Inventories $8,678$8,678$8,765$8,144$8,053
Total Cash $0$0$0$0$0
Current Assets $47,194$47,194$43,088$65,032$60,210
Total Assets $155,703$155,703$157,303$141,208$133,411
Short Term Debt $1,773$1,773$3,906$4,684$7,004
Accounts Payable $7,000$7,000$7,310$6,918$6,668
Total Current Liabilities $27,437$27,437$30,537$26,287$27,747
Long Term Debt $29,480$29,480$30,675$22,442$12,857
Deferred Tax Liabilities $7,711$7,711$8,368$2,910$2,562
Total Liabilities $91,077$91,077$97,143$70,790$62,261
Total Stock Holders Equity $64,626$64,626$60,160$70,418$71,150
Total Equity $64,626$64,626$60,160$70,418$71,150
  TTM2018201720162015
Operating Cash Flow $0$0$0$0$0
Investing Cash Flow -$5,900-$5,395-$14,868-$4,761-$7,735
Dividends Paid $9,339$7,083$8,943$8,621$8,173
Financing Cash Flow -$15,658-$12,121-$7,673-$8,551-$10,846
Free Cash Flow $18,305$13,557$17,543$15,418$15,713

Unique Data Points

  TTM2018201720162015
Customer Revenue $81,382$61,187$76,450$71,890$70,074
Sales to Customers Revenue $81,382$61,187$76,450$71,890$70,074
Selling, Marketing & Administrative Expense $22,574$16,549$21,420$19,945$21,203
Shares Outstanding $2,732$2,732$2,685$2,765$2,803
Asia-Pacific & Africa Customer Revenue $14,731$11,252$13,420$12,575$12,347
Europe Customer Revenue $18,751$14,023$17,126$15,925$15,995
International Advanced Revenue $2,324$1,731$2,136$1,993$1,845
International Babycare Revenue $1,446$1,079$1,467$1,400$1,629
International Beauty Care Revenue $1,994$1,480$1,865$1,762$461
International Cardiovascular Revenue $282$0$1,025$901$1,105
International CARDIOVASCULAR / METABOLISM Revenue $1,562$1,196$1,518$1,541$1,659
International Concerta & Methylphenidate Revenue $425$322$407$395$387
International Consumer Revenue $8,196$6,035$8,037$7,887$8,285
International CONTACT LENSES / OTHER Revenue $2,048$1,538$1,914$1,715--
International Customer Revenue $39,658$29,932$36,587$34,079$34,387
International Darzalex Revenue $955$825$771$200--
International Diabetes Care Revenue $898$638$1,003$1,050$1,095
International Diagnostics Revenue $0$0$1$66$86
International Edurant Revenue $759$581$656$521$369
International General Revenue $2,812$2,094$2,735$2,693$2,780
International Hips Revenue $581$432$567$563$408
International Imbruvica Revenue $1,404$1,101$1,052$638$314
International Immunology Revenue $3,920$3,061$3,373$3,122$2,760
International Infectious Diseases Revenue $1,958$1,496$1,796$1,747$2,121
International Invega Sustenna, Xeplion & Trinza Revenue $1,116$859$979$871$745
International INVOKANA / INVOKAMET Revenue $176$130$167$134$70
International Knees Revenue $589$438$575$581$430
International Medical Devices Revenue $14,363$10,703$13,768$12,853$13,005
International Neuroscience Revenue $3,488$2,663$3,356$3,457$3,409
International Oncology Revenue $5,235$4,087$4,160$3,472$3,148
International OPSUMIT Revenue $504$381$253----
International Oral Care Revenue $921$684$915$920$951
International Orthopaedics Revenue $3,650$2,700$3,777$3,813$3,882
International OTHER / CARDIOVASCULAR / METABOLISM Revenue $1,074$822$1,054$1,069$1,213
International Other Immunology Revenue $68$65$23$25$39
International OTHER INFECTIOUS DISEASES Revenue $401$302$428$513$558
International Other Neuroscience Revenue $1,516$1,161$1,614$1,828$1,521
International Other Oncology Revenue $360$269$359$390$340
International OTHER PULMONARY HYPERTENSION Revenue $65$47$59----
International Over the Counter Revenue $2,526$1,827$2,410$2,357$2,408
International Pharmaceutical Customer Revenue $17,099$13,194$14,782$13,339$13,097
International PREZISTA / PREZCOBIX / REZOLSTA Revenue $798$613$712$708$746
International PROCRIT / EPREX Revenue $312$244$297$338$376
International Pulmonary Hypertension Revenue $936$691$579----
International Remicade Revenue $1,199$921$1,227$1,342$1,326
International Risperdal Consta Revenue $431$321$445$512$561
International Simponi/Simponi Aria Revenue $1,060$823$879$816$598
International Specialty Revenue $629$458$603$584$601
International Spine & Other Revenue $1,379$1,001$1,595$1,645$1,251
International Stelara Revenue $1,593$1,252$1,244$969$797
International Surgery Revenue $5,765$4,283$5,474$5,270$5,226
International Surgical Revenue $707$531$574----
International TRACLEER Revenue $305$214$242----
International Trauma Revenue $1,101$829$1,040$1,024$774
International UPTRAVI Revenue $62$49$25----
International Velcade Revenue $1,135$864$1,114$1,224$1,333
International Vision Care Revenue $2,755$2,069$2,488$1,753$1,611
International Womens Health Revenue $1,041$782$1,038$1,038$1,174
International Wound Care Revenue $268$183$342$348$420
International Zytiga Revenue $1,645$1,292$1,277$1,171$1,161
US Advanced Revenue $1,646$1,216$1,620$1,524$1,430
US Baby Care Revenue $429$306$449$442$444
US Beauty Care Revenue $2,387$1,791$2,335$2,135$442
US Cardiovascular Revenue $286$0$1,071$948$931
US CARDIOVASCULAR / METABOLISM Revenue $4,486$3,230$4,725$4,855$4,759
US Concerta & Methylphenidate Revenue $291$191$384$468$434
US Consumer Revenue $5,661$4,282$5,565$5,420$5,222
US CONTACT LENSES / OTHER Revenue $1,238$948$1,122$1,050--
US Customer Revenue $41,724$31,255$39,863$37,811$35,687
US Darzalex Revenue $1,121$880$884$151--
US Diabetes Care Revenue $501$371$612$739$833
US Diagnostics Revenue $0$0$0$0$0
US Edurant Revenue $56$42$58$52$41
US General Revenue $1,734$1,282$1,728$1,669$1,702
US Hips Revenue $836$621$827$798$591
US Imbruvica Revenue $1,030$811$841$613$375
US Immunology Revenue $8,944$6,717$8,871$8,846$7,642
US INFECTIOUS DISEASES Revenue $1,344$1,006$1,358$1,461$1,535
US Invega Sustenna, Xeplion & Trinza Revenue $1,742$1,306$1,590$1,343$1,085
US INVOKANA / INVOKAMET Revenue $744$523$944$1,273$1,238
US Knees Revenue $918$672$948$943$690
US Medical Devices Revenue $12,937$9,623$12,824$12,266$12,132
US Neuroscience Revenue $2,613$1,914$2,630$2,628$2,850
US Oncology Revenue $4,159$3,268$3,098$2,335$1,587
US OPSUMIT Revenue $657$511$320----
US Oral Care Revenue $628$472$616$648$629
US Orthopaedics Revenue $5,312$3,923$5,481$5,521$5,380
us OTHER / CARDIOVASCULAR / METABOLISM Revenue $476$315$606$527$961
US Other Immunology Revenue $357$311$62----
US OTHER INFECTIOUS DISEASES Revenue $156$117$191$261$257
US Other Neuroscience Revenue $255$179$296$390$583
US Other Oncology Revenue $186$157$145$381$82
US OTHER PULMONARY HYPERTENSION Revenue $89$63$73----
US Over the Counter Revenue $1,765$1,359$1,716$1,633$1,540
US Pharmaceutical Customer Revenue $23,126$17,350$21,474$20,125$18,693
US PREZISTA / PREZCOBIX / REZOLSTA Revenue $1,132$847$1,109$1,143$1,064
US PROCRIT / EPREX Revenue $687$523$675$767$692
US Pulmonary Hypertension Revenue $1,580$1,215$792----
US Remicade Revenue $3,894$2,821$4,525$4,842$4,453
US Risperdal Consta Revenue $325$238$360$381$409
US Simponi/Simponi Aria Revenue $1,032$779$954$959$730
US Specialty Revenue $727$533$737$833$859
US Spine & Other Revenue $1,965$1,434$2,130$2,235$1,692
US Stelara Revenue $3,200$2,460$2,767$2,263$1,677
US Surgery Revenue $4,107$3,031$4,085$4,026$3,911
US Surgical Revenue $546$403$453----
US TRACLEER Revenue $284$208$161----
US Trauma Revenue $1,593$1,196$1,576$1,545$1,098
US UPTRAVI Revenue $550$433$238----
US Vision Care Revenue $1,784$1,351$1,575$1,032$997
US Womens Health Revenue $13$10$12$19$26
US Wound Care Revenue $439$344$437$522$723
US XARELTO Revenue $2,579$1,869$2,500$2,288$1,868
US Zytiga Revenue $1,822$1,420$1,228$1,089$1,070
US Exports Remicade Revenue $461$346$563$838$782
Western Hemisphere Customer Revenue $6,176$4,657$6,041$5,734$6,045
Worldwide Advanced Revenue $3,970$2,947$3,756$3,517$3,275
Worldwide Babycare Revenue $1,875$1,385$1,916$2,001$2,044
Worldwide Beauty Care Revenue $4,381$3,271$4,200$3,897$903
Worldwide Cardiovascular Revenue $568$0$2,096$1,849$2,036
Worldwide Cardiovascular / Metabolism Revenue $6,048$4,426$6,243$6,396$6,418
Worldwide Concerta & Methylphenidate Revenue $716$513$791$863$821
Worldwide Consumer Revenue $13,857$10,317$13,602$13,307$13,507
Worldwide Contact Lenses / Other Revenue $3,286$2,486$3,036$2,765--
Worldwide Darzalex Revenue $1,812$1,441$1,242$200--
Worldwide Diabetes Care Revenue $1,399$1,009$1,615$1,789$1,928
Worldwide Diagnostics Revenue $0$0$1$66$86
Worldwide Edurant Revenue $815$623$714$573$410
Worldwide General Revenue $3,377$2,207$4,463$4,362$4,482
Worldwide Hips Revenue $1,417$1,053$1,394$1,361$999
Worldwide Imbruvica Revenue $2,434$1,912$1,893$1,251$689
Worldwide Immunology Revenue $12,864$9,778$12,244$11,968$10,402
Worldwide Infectous Diseases Revenue $3,302$2,502$3,154$3,208$3,656
Worldwide Invega Sustenna, Xeplion & Trinza Revenue $2,858$2,165$2,569$2,214$1,830
Worldwide INVOKANA / INVOKAMET Revenue $920$653$1,111$1,407$1,308
Worldwide Knees Revenue $1,507$1,110$1,277$581$430
Worldwide Medical Devices Revenue $27,300$20,326$26,592$25,119$25,137
Worldwide Neuroscience Revenue $6,101$4,577$5,986$6,085$6,259
Worldwide Oncology Revenue $9,394$7,355$7,258$5,807$4,695
Worldwide OPSUMIT Revenue $1,161$892$573----
Worldwide Oral Care Revenue $1,549$1,156$1,531$1,568$1,580
Worldwide Orthopaedics Revenue $8,962$6,623$9,258$9,334$9,262
Worldwide Other / Cardiovascular / Metabolism Revenue $1,550$1,137$1,660$1,596$2,174
Worldwide Other Immunology Revenue $123$74$85$25$39
Worldwide Other Infectious Diseases Revenue $557$419$619$774$815
Worldwide Other Neuroscience Revenue $1,771$1,340$1,821$1,890$2,065
Worldwide Other Oncology Revenue $546$426$504$771$422
Worldwide Other Pulmonary Hypertension Revenue $154$110$132----
Worldwide Over the Counter Revenue $4,291$3,186$4,126$3,977$3,975
Worldwide Pharmaceutical Customer Revenue $40,225$30,544$36,256$33,464$31,430
Worldwide PREZISTA / PREZCOBIX / REZOLSTA Revenue $1,930$1,460$1,821$1,851$1,810
Worldwide PROCRIT / EPREX Revenue $999$767$972$1,105$1,068
Worldwide Pulmonary Hypertension Revenue $2,516$1,906$1,371----
Worldwide Remicade Revenue $5,554$4,088$6,315$6,966$6,561
Worldwide Risperdal Consta Revenue $756$559$805$893$970
Worldwide Simponi/Simponi Aria Revenue $2,092$1,602$1,833$1,745$1,328
Worldwide Skincare Revenue $0$0$0$3,897$3,531
Worldwide Specialty Revenue $1,356$991$1,340$1,417$1,460
Worldwide Spine & Other Revenue $3,344$2,435$3,725$3,880$2,943
Worldwide Stelara Revenue $4,793$3,712$4,011$3,232$2,474
Worldwide Surgery Revenue $9,872$7,314$9,559$9,296$9,217
Worldwide Surgical Revenue $1,253$934$1,027----
Worldwide TRACLEER Revenue $589$422$403----
Worldwide Trauma Revenue $2,694$2,025$2,616$2,569$1,872
Worldwide UPTRAVI Revenue $612$482$263----
Worldwide Velcade Revenue $1,135$864$1,114$1,224$1,333
Worldwide Vision Care Revenue $4,539$3,420$4,063$2,785$2,608
Worldwide Womens Health Revenue $1,054$792$1,050$1,067$1,200
Worldwide Wound Care/Other Revenue $707$527$779$797$1,177
Worldwide XARELTO Revenue $2,579$1,869$2,500$2,288$1,868
Worldwide Zytiga Revenue $3,467$2,712$2,505$2,290$2,231